Search
Search Results for “Pfizer”
Showing results 121 - 126 of 126
-
Cancer & COVID-19 Risk: A Q&A with Dr. Gary Lyman
https://www.drugwatch.com/news/2021/02/08/cancer-covid-19-risk-qa-dr-gary-lyman/Q: Should cancer patients receive the COVID-19 vaccine? A: The two currently available vaccines from Pfizer/BioNTech and Moderna have not been ... -
Valsartan Manufacturers and Distributors
https://www.drugwatch.com/valsartan/manufacturers/Novartis originally manufactured valsartan blood pressure medication under the brand name Diovan. The U.S. Food and Drug Administration first approved Diovan in ... -
Ranitidine Cancer Lawsuits Move Forward in Florida After ...
https://www.drugwatch.com/news/2020/02/26/ranitidine-cancer-lawsuits-florida-zantac-recalls/... Pfizer. The newly formed MDL contains both individual cases alleging personal injuries and putative class actions seeking refunds and other ... -
Testosterone Treatment May Not Help Men's Sexual ...
https://www.drugwatch.com/news/2015/07/17/testosterone-may-not-help-sexual-performance/Testosterone Trials to Begin October 2016. Drug manufacturers Abbott, AbbVie, Auxillium Pharmaceuticals, Pfizer and others are currently facing ... -
'Side Effects' Shines Weak Light on Dark ...
https://www.drugwatch.com/news/2013/02/14/side-effects-movie-antidepressants/As a result, more than a 100 Zoloft birth defect lawsuits against Pfizer are pending in multidistrict litigation (MDL) in the U.S. District ... -
Amanda Gerberich, Pharm.D. BCPS | Medical Reviewer
https://www.drugwatch.com/contributors/amanda-gerberich/Amanda Gerberich, PharmD is a Clinical Assistant Professor at UIC College of Pharmacy whose areas of interest include drug information and ...
Calling this number connects you with a Drugwatch.com representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch.com's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.